GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jagsonpal Pharmaceuticals Ltd (NSE:JAGSNPHARM) » Definitions » Capital Expenditure

Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Capital Expenditure : ₹0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Jagsonpal Pharmaceuticals Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Jagsonpal Pharmaceuticals's cash flow for capital expenditures for the three months ended in Mar. 2025 was ₹0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00 Mil.

Jagsonpal Pharmaceuticals Capital Expenditure Historical Data

The historical data trend for Jagsonpal Pharmaceuticals's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jagsonpal Pharmaceuticals Capital Expenditure Chart

Jagsonpal Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.69 -10.49 -3.18 -2.48 -3.48

Jagsonpal Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Jagsonpal Pharmaceuticals Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jagsonpal Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jagsonpal Pharmaceuticals Ltd (NSE:JAGSNPHARM) » Definitions » Capital Expenditure
Comparable Companies
BOM:506197 BOM:530199 BOM:524669 BOM:543389 BOM:531633 NSE:BETA BOM:506260 BOM:539997 BOM:539872 BOM:524470 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
507789:India
Address
3rd Floor, Phase – IV, Udyog Vihar, Plot No. 412-415, Nimai Tower, Gurugram, HR, IND, 122015
Website
https://www.jagsonpal.com
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Metadec, Metabol, Doxypal DR, and others.

Jagsonpal Pharmaceuticals Headlines

No Headlines